#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Clear cell renal cell carcinoma+1

Recruiting

InvestigationalNo placebo

Study of XL092 and belzutifan combination therapy in people with clear cell kidney cancer who had disease return during or after immunotherapy treatment

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Sarcoma+4

Recruiting

InvestigationalNo placebo

Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Zanidatamab

Contact Research Centre

Evaluation of Choline Chloride for Intestinal Failure Patients Receiving Long-Term Parenteral Support

Recruiting

Investigational

Evaluation of Choline Chloride for Intestinal Failure Patients Receiving Long-Term Parenteral Support

Investigational

France

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Neuroblastoma

Recruiting

Registered drugNo placebo

Study of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years
Substances:Bevacizumab

Contact Research Centre

Hypertrophic cardiomyopathy

Recruiting

Registered drugNo placebo

Study Evaluating Direct Oral Anticoagulants for Prevention of Blood Clots in Patients with Hypertrophic Cardiomyopathy and Abnormal Left Atrial Function

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Rivaroxaban

Contact Research Centre

Head and neck cancer

Recruiting

Registered drugNo placebo

Study of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Non-small cell lung cancer+2

Recruiting

Registered drugNo placebo

Study Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study Comparing Tepotinib to Standard Treatment for Patients with Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Haematological malignancy+1

Recruiting

InvestigationalNo placebo

Study on Fecal Microbiota Transplantation to Prevent Complications in Patients After Stem Cell Transplant for Blood Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Allogeneic Faecal Microbiota

Contact Research Centre

Multiple sclerosis

Recruiting

InvestigationalNo placebo

Study of [18F]-DPA-714 PET imaging to assess neuroinflammation in multiple sclerosis patients compared to healthy controls

InvestigationalNo placebo

France

Participants:18–64 years · Healthy volunteers
Substances:N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide

Contact Research Centre

Hormone-refractory prostate cancer+1

Recruiting

Registered drugNo placebo

Study Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Codeine Phosphate

Contact Research Centre

Non-small cell lung cancer metastatic

Recruiting

Registered drug

Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.